Pipex Pharmaceuticals Receives State of Michigan Economic Development Corporation - MEDC Job Training Grant

Published: Sep 17, 2007

ANN ARBOR, MI--(MARKET WIRE)--Sep 17, 2007 -- Pipex Pharmaceuticals, Inc. ("Pipex") (AMEX:PP - News), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced today that it was notified by the Michigan Economic Development Corporation (MEDC) that Pipex has received a Michigan Economic Development Job Training Grant (EDJT) to support the training of Pipex employees involved in the cGMP pharmaceutical production of its lead product, COPREXA (oral tetrathiomolybdate) for neurologically-presenting Wilson's disease and potential additional product candidates of Pipex.

Back to news